The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor | BMC Medicine | Full Text
The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
August 6, 2014 – Beyond the Dish
Figure 2 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
KIT (gene) - Wikipedia
Activated c-Kit receptor in the heart promotes cardiac repair and regeneration after injury | Cell Death & Disease
c-Kit Protein Overview: Sequence, Structure, Function and Protein Interaction | Sino Biological
Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition | PNAS
The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer | SpringerLink
Stem Cell Factor Receptor/c-Kit: From Basic Science to Clinical Implications | Physiological Reviews
Structure of c-KIT receptor tyrosine kinase. | Download Scientific Diagram
PDF] Kit ligand and c-Kit have diverse roles during mammalian oogenesis and folliculogenesis. | Semantic Scholar
Hormonal regulation of c-KIT receptor and its ligand: implications for human infertility? - ScienceDirect
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
c-キッ阻害 | c-Kit Inhibition
IJMS | Free Full-Text | Possible Prognostic and Therapeutic Significance of c-Kit Expression, Mast Cell Count and Microvessel Density in Renal Cell Carcinoma
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition | PNAS
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors | Oncogene
IJMS | Free Full-Text | Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia